BECTON, DICKINSON AND COMPANY Defined Benefit Plan, Effect of Plan Amendment on Net Periodic Benefit Cost (Deprecated 2017-01-31)
BECTON, DICKINSON AND COMPANY (BDX) had Defined Benefit Plan, Effect of Plan Amendment on Net Periodic Benefit Cost (Deprecated 2017-01-31) of $40.00 million as of 2012-09-30, per its 8-K filed 2015-03-13.
Discontinued › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Net Periodic Benefit Cost (Credit)
us-gaap:DefinedBenefitPlanEffectOfPlanAmendmentOnNetPeriodicBenefitCost · last filed 2015-03-13
- 2012-09-30: Defined Benefit Plan, Effect of Plan Amendment on Net Periodic Benefit Cost (Deprecated 2017-01-31) $40.00M; Defined Benefit Plan, Effect of Plan Amendment on Net Periodic Benefit Cost (Deprecated 2017-01-31) as first filed $40.20M.
- 2012-06-30: Defined Benefit Plan, Effect of Plan Amendment on Net Periodic Benefit Cost (Deprecated 2017-01-31) $40.20M.
- 2012-03-31: Defined Benefit Plan, Effect of Plan Amendment on Net Periodic Benefit Cost (Deprecated 2017-01-31) $40.20M.
- 2011-12-31: Defined Benefit Plan, Effect of Plan Amendment on Net Periodic Benefit Cost (Deprecated 2017-01-31) $40.20M.
| Period end | Defined Benefit Plan, Effect of Plan Amendment on Net Periodic Benefit Cost (Deprecated 2017-01-31) | Defined Benefit Plan, Effect of Plan Amendment on Net Periodic Benefit Cost (Deprecated 2017-01-31) as first filed |
|---|---|---|
| 2012-09-30 | $40.00M 8-K · filed 2015-03-13 | $40.20M 10-K · filed 2012-11-21 |
| 2012-06-30 | $40.20M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $40.20M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | $40.20M 10-Q · filed 2012-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |